AJADUO | EMPAGLIFLOZIN + LINAGLIPTIN | |
BUDAMATE | BUDESONIDE + FORMOTEROL | |
CETIL | CEFUROXIME AXETIL | |
CIDMUS | SACUBITRIL + VALSARTAN | |
CLOPITAB | CLOPIDOGREL BISULFATE | |
FERINJECT | IRON FERRIC CARBOXYMALTOSE | |
GIBTULIO | EMPAGLIFLOZIN | |
GLUCONORM-G | GLIMEPIRIDE + METFORMIN | |
HUMINSULIN | INSULIN HUMAN BASE RECOMBINANT + INSULIN HUMAN ISOPHANE RECOMBINANT | |
IVABRAD | IVABRADINE | |
LUPIHEME | IRON METAL | |
LUPISULIN-M | INSULIN HUMAN BASE RECOMBINANT + INSULIN HUMAN ISOPHANE RECOMBINANT | |
MEROTROL | MEROPENEM | |
ONDERO | LINAGLIPTIN | |
RABLET | RABEPRAZOLE | |
SIGNOFLAM | ACECLOFENAC + PARACETAMOL + SERRAPEPTASE | |
TAZAR | PIPERACILLIN + TAZOBACTAM | |
TELEKAST-L | LEVOCETIRIZINE + MONTELUKAST | |
TONACT | ATORVASTATIN | |
Pingback: USFDA approves Lupin’s Posaconazole tablets > PharmaCampus